• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上市后安全性评估。

Safety assessment post-licensure.

作者信息

Miller E, Waight P, Farrington P

机构信息

PHLS Communicable Disease Surveillance Centre, London, UK.

出版信息

Dev Biol Stand. 1998;95:235-43.

PMID:9855437
Abstract

The objectives of post-licensure surveillance are to identify rare or novel adverse events, estimate their rate of occurrence and distinguish those that are causally related to vaccination. Evidence of causality is based on biological plausibility supported by laboratory evidence of vaccine involvement and/or a statistically significant excess of events in the post-vaccination period. Passive reporting systems have methodological limitations, particularly for ascertaining reliable adverse event rates and investigating causal relationships. In Canada, an active surveillance system (IMPACT) has been established in sentinel paediatric hospitals where nurses scrutinise all admissions for conditions conforming to a defined set of adverse events. While ascertainment of events resulting in hospital admission should be complete, causality is difficult to assess without information on the incidence of such events outside the post-vaccination risk period. The use of computerised data bases which link clinical events with immunisation records have allowed the risk of events such as convulsions attributable to DTP, MMR and Hib vaccines to be defined. The record linkage method promises to be a useful method for routine surveillance of vaccine safety.

摘要

上市后监测的目的是识别罕见或新出现的不良事件,估计其发生率,并区分那些与疫苗接种有因果关系的事件。因果关系的证据基于生物学合理性,并得到疫苗相关实验室证据和/或接种疫苗后时期事件统计学上显著过量的支持。被动报告系统存在方法学上的局限性,特别是在确定可靠的不良事件发生率和调查因果关系方面。在加拿大,已在定点儿科医院建立了一个主动监测系统(IMPACT),护士在这些医院仔细检查所有符合一组定义不良事件的入院情况。虽然导致住院的事件的确定应该是完整的,但如果没有接种疫苗后风险期之外此类事件发生率的信息,就很难评估因果关系。将临床事件与免疫记录相链接的计算机数据库的使用,使得能够确定诸如白百破、麻疹腮腺炎风疹和b型流感嗜血杆菌疫苗所致惊厥等事件的风险。记录链接方法有望成为疫苗安全性常规监测的一种有用方法。

相似文献

1
Safety assessment post-licensure.上市后安全性评估。
Dev Biol Stand. 1998;95:235-43.
2
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.免疫接种后安全性监测:疫苗不良事件报告系统(VAERS)——美国,1991 - 2001年
MMWR Surveill Summ. 2003 Jan 24;52(1):1-24.
3
[Safety surveillance in the National Vaccination Programme; fewer adverse events with the DTP-IPV-Hib vaccine after the transition to an acellular pertussis component in 2005].[国家疫苗接种计划中的安全监测;2005年转用无细胞百日咳成分后,百白破-灭活脊髓灰质炎疫苗- Hib疫苗的不良事件减少]
Ned Tijdschr Geneeskd. 2007 Dec 8;151(49):2732-7.
4
Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention.评估疫苗上市后安全性面临的挑战:来自疾病预防控制中心的观察。
Expert Rev Vaccines. 2019 Oct;18(10):1091-1101. doi: 10.1080/14760584.2019.1676154. Epub 2019 Oct 19.
5
Post-licensure rapid immunization safety monitoring program (PRISM) data characterization.疫苗上市后快速免疫安全性监测项目(PRISM)数据特征描述。
Vaccine. 2013 Dec 30;31 Suppl 10:K98-112. doi: 10.1016/j.vaccine.2013.04.088.
6
Post-authorization safety surveillance of a liquid pentavalent vaccine in Guatemalan children. Guatemalan 儿童中五价液体制剂疫苗的上市后安全性监测。
Vaccine. 2013 Dec 2;31(49):5909-14. doi: 10.1016/j.vaccine.2013.09.015. Epub 2013 Sep 19.
7
Surveillance of adverse events following immunisation: Australia, 2000-2002.2000 - 2002年澳大利亚免疫接种后不良事件监测
Commun Dis Intell Q Rep. 2003;27(3):307-23.
8
Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.理解人类变异在疫苗不良反应中的作用:临床免疫安全评估网络。
Pediatrics. 2011 May;127 Suppl 1:S65-73. doi: 10.1542/peds.2010-1722J. Epub 2011 Apr 18.
9
[Vaccines: adverse events surveillance].[疫苗:不良事件监测]
Rev Chilena Infectol. 2007 Feb;24(1):53-6. doi: 10.4067/s0716-10182007000100008. Epub 2007 Mar 8.
10
Vaccine adverse events reported in New Zealand 1990-5.1990 - 1995年新西兰报告的疫苗不良事件。
N Z Med J. 1997 Jul 25;110(1048):270-2.

引用本文的文献

1
Using electronic medical records to enhance detection and reporting of vaccine adverse events.利用电子病历加强疫苗不良事件的检测与报告。
J Am Med Inform Assoc. 2007 Nov-Dec;14(6):731-5. doi: 10.1197/jamia.M2232. Epub 2007 Aug 21.
2
No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome.肾病综合征患者接种C群脑膜炎球菌结合疫苗后复发风险未增加。
Arch Dis Child. 2007 Oct;92(10):887-9. doi: 10.1136/adc.2006.105247. Epub 2007 Apr 27.
3
No evidence of an association between MMR vaccine and gait disturbance.
没有证据表明麻疹、腮腺炎和风疹联合疫苗与步态障碍之间存在关联。
Arch Dis Child. 2005 Mar;90(3):292-6. doi: 10.1136/adc.2003.048165.
4
Health protection and a new strategy for combating infection in children.儿童健康保护与抗击感染的新策略
Arch Dis Child. 2003 Jan;88(1):1-3. doi: 10.1136/adc.88.1.1.
5
Does oral polio vaccine cause intussusception in infants? Evidence from a sequence of three self-controlled cases series studies in the United Kingdom.口服脊髓灰质炎疫苗会导致婴儿肠套叠吗?来自英国三项自我对照病例系列研究的证据。
Eur J Epidemiol. 2001;17(8):701-6. doi: 10.1023/a:1015691619745.
6
Vaccine trials.疫苗试验。
Mol Biotechnol. 2001 Jan;17(1):43-58. doi: 10.1385/MB:17:1:43.